BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-302@pharmaconomics
DTSTAMP:20260707T034434Z
DTSTART;VALUE=DATE:20260113
DTEND;VALUE=DATE:20260114
SUMMARY:TVTX PDUFA — FILSPARI
DESCRIPTION:The FDA's approval decision on FILSPARI for IgA Nephropathy (IgAN) is due Jan 13\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1438533/000143853326000003/aex991_2025q4xearningsprex.htm\n\nTrack it: https://www.pharmaconomics.com/e/302
URL:https://www.pharmaconomics.com/e/302
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:TVTX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR